| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.011 | 0.8 |